1x26
From Proteopedia
(Difference between revisions)
Line 3: | Line 3: | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[1x26]] is a 2 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1X26 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1X26 FirstGlance]. <br> | <table><tr><td colspan='2'>[[1x26]] is a 2 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1X26 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1X26 FirstGlance]. <br> | ||
- | </td></tr><tr><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NAZ:N~3~-{3-[(7-METHYL-1,8-NAPHTHYRIDIN-2-YL)AMINO]-3-OXOPROPYL}-N~1~-[(7-OXO-7,8-DIHYDRO-1,8-NAPHTHYRIDIN-2-YL)METHYL]-BETA-ALANINAMIDE'>NAZ</scene>< | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NAZ:N~3~-{3-[(7-METHYL-1,8-NAPHTHYRIDIN-2-YL)AMINO]-3-OXOPROPYL}-N~1~-[(7-OXO-7,8-DIHYDRO-1,8-NAPHTHYRIDIN-2-YL)METHYL]-BETA-ALANINAMIDE'>NAZ</scene></td></tr> |
- | <tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1x26 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1x26 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=1x26 RCSB], [http://www.ebi.ac.uk/pdbsum/1x26 PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1x26 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1x26 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=1x26 RCSB], [http://www.ebi.ac.uk/pdbsum/1x26 PDBsum]</span></td></tr> |
- | <table> | + | </table> |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 18: | Line 18: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: Goto, Y | + | [[Category: Goto, Y]] |
- | [[Category: Hagihara, M | + | [[Category: Hagihara, M]] |
- | [[Category: Hagihara, S | + | [[Category: Hagihara, S]] |
- | [[Category: Hayashi, G | + | [[Category: Hayashi, G]] |
- | [[Category: Kobori, A | + | [[Category: Kobori, A]] |
- | [[Category: Kojima, C | + | [[Category: Kojima, C]] |
- | [[Category: Kyo, M | + | [[Category: Kyo, M]] |
- | [[Category: Mishima, M | + | [[Category: Mishima, M]] |
- | [[Category: Nakatani, K | + | [[Category: Nakatani, K]] |
- | [[Category: Nomura, M | + | [[Category: Nomura, M]] |
[[Category: Aa mismatch]] | [[Category: Aa mismatch]] | ||
[[Category: Dna]] | [[Category: Dna]] | ||
[[Category: Drug]] | [[Category: Drug]] |
Revision as of 22:26, 3 January 2015
Solution structure of the AA-mismatch DNA complexed with naphthyridine-azaquinolone
|
Categories: Goto, Y | Hagihara, M | Hagihara, S | Hayashi, G | Kobori, A | Kojima, C | Kyo, M | Mishima, M | Nakatani, K | Nomura, M | Aa mismatch | Dna | Drug